Literature DB >> 21558777

Hospital-wide reduction in central line-associated bloodstream infections: a tale of two small community hospitals.

Aysegul Gozu1, Colleen Clay, Faheem Younus.   

Abstract

Despite increasing awareness of central line-associated bloodstream infections (CLABSIs) in general wards, published strategies come from intensive care units (ICUs) of large tertiary care centers. After implementing a central line insertion checklist, two community hospitals experienced an 86% reduction in CLABSI rates in ICUs and a 57% reduction in non-ICU settings over 36 months.

Mesh:

Year:  2011        PMID: 21558777     DOI: 10.1086/660098

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  3 in total

Review 1.  Prevention of central line-associated bloodstream infections through quality improvement interventions: a systematic review and meta-analysis.

Authors:  Koen Blot; Jochen Bergs; Dirk Vogelaers; Stijn Blot; Dominique Vandijck
Journal:  Clin Infect Dis       Date:  2014-04-09       Impact factor: 9.079

2.  Device-associated infection rates, mortality, length of stay and bacterial resistance in intensive care units in Ecuador: International Nosocomial Infection Control Consortium's findings.

Authors:  Estuardo Salgado Yepez; Maria M Bovera; Victor D Rosenthal; Hugo A González Flores; Leonardo Pazmiño; Francisco Valencia; Nelly Alquinga; Vanessa Ramirez; Edgar Jara; Miguel Lascano; Veronica Delgado; Cristian Cevallos; Gasdali Santacruz; Cristian Pelaéz; Celso Zaruma; Diego Barahona Pinto
Journal:  World J Biol Chem       Date:  2017-02-26

3.  Epidemiology and impact of a multifaceted approach in controlling central venous catheter associated blood stream infections outside the intensive care unit.

Authors:  José Francisco García-Rodríguez; Hortensia Álvarez-Díaz; Laura Vilariño-Maneiro; María Virginia Lorenzo-García; Ana Cantón-Blanco; Patricia Ordoñez-Barrosa; Ana Isabel Mariño-Callejo; Pascual Sesma-Sánchez
Journal:  BMC Infect Dis       Date:  2013-09-24       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.